Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Multi-Center, Double-Blind, Placebo-Controlled Study of Nitazoxanide Suspension in the Treatment of Diarrhea Caused by Entamoeba Histolytica in Children

NCT00366730 is registered in ClinicalTrials.gov with Romark Laboratories L.C. as lead sponsor.

NCT NCT00366730
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00366730 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Multi-Center, Double-Blind, Placebo-Controlled Study of Nitazoxanide Suspension in the Treatment of Diarrhea Caused by Entamoeba Histolytica in Children
Lead sponsor
Romark Laboratories L.C.
Phase
Phase 3
Overall status
Completed
Start date
February 29, 2004
Completion date
November 30, 2005
Enrollment
50
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

amebiasis